Clinical Trial Update: 8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing valsartan combined with aliskiren versus valsartan alone in Stage 2 Hypertension to assess efficacy and safety; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• DIOVAN (valsartan)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Stage 2 Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-05-02